UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

June 26, 2006

 

VisualMED Clinical Solutions Corp.

(Exact name of registrant as specified in its charter)

 

NEVADA

000-33191

88-0436055

(State or other jurisdiction of incorporation)

(Commission File No.)

(IRS Employer ID)

 

1035 Laurier Street West

Montreal, Quebec H2V 2L1

(Address of principal executive offices and Zip Code)

 

(514) 274-1115

(Registrant's telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[   ]

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[   ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[   ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[   ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 



 

 

Item 7.01

Regulation FD Disclosure

VisualMED Clinical Solutions Corp. has appointed Mr. Chris Marcolefas to its Board of Directors.

Mr. Marcolefas will sit as an independent member, as well as chair the Company’s audit committee.

Mr. Marcolefas has extensive experience with companies involved in the development and marketing of new and cutting-edge technologies. He is currently Vice President of Operations at TouchTunes Music Corporation, a leader in the development and marketing of advanced electronic audio devices.

 

Item 9.01

Financial Statements and Exhibits

Exhibit 99.1

Press Release dated June 23, 2006

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated this 23rd day of June, 2006.

VisualMED Clinical Solutions Corp.

By:

/s/ Gerard Dab

 

 

Gerard Dab, Chairman, CEO